Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-17.63	24.23	29.42
Graham Fair Price	20.40	61.33	50.94
PEG	-4.44	0.45	-0.47
Price/Book	-5.97	4.34	4.62
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-18.45	12.96	15.89
Price/Sales	-4.65	6.73	7.06
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	4.46	0.40	0.38
Operating Margin	19.55	0.23	0.19
ROA	24.24	0.03	0.02
ROE	0.07	0.08	15.30
ROIC	0.04	0.05	21.11
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.02	0.02	-0.11
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.06	0.32	461.53
EPS QOQ	-0.34	0.29	-14.66
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	0.07	0.11	42.86
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	20.98	20.02	-4.59
Days Sales Outstanding (DSO)	20.24	12.50	-38.23
Inventory Turnover	4.29	4.50	4.81
Debt/Capitalization	0.56	0.53	-5.87
Quick Ratio	3.46	3.67	6.13
Naive Interpretation	member

04 - Leverage & Liquidity · Positive

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	39.83	44.67	12.13
Cash	52.06	53.12	2.02
Capex	0.00	n.A.	n.A.
Free Cash Flow	0.00	n.A.	n.A.
Revenue	26.05	28.81	10.58
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	3.93	4.15	5.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.07	-0.32	-362.88
Naive Interpretation	Member

06 - Financial Health · Bad

Rating